NASDAQ · Biotechnology

CAMP (CAMP) Stock

$3.47 +6.12% NASDAQ: CAMP Healthcare

Valuation

MetricValue
Price$3.47
Market Cap$73.70M
P/E Ratio-1.70
P/B Ratio2.00
P/S Ratio24.35
EPS (TTM)$0.00
52-Week High$7.75
52-Week Low$1.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-166.67%
ROA-67.80%
ROCE-108.33%
Gross Margin-1766.67%
Operating Margin-1733.33%
Net Margin-21.94%
Debt/Equity0.07
Current Ratio7.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$296.0M$0$0$1.0M$3.0M
Operating Profit$-15.0M$-45.0M$-52.0M$-53.0M$-52.0M
Net Profit$-31.0M$-44.0M$-49.0M$-52.0M$-80.0M
EPS$-0.88$-0.90$-4.07$-2.66$-2.65
Op Margin-5.2%—-14822.6%-8142.3%-1488.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$402.0M$103.0M$55.0M$78.0M$118.0M
Total Liabilities$322.0M$180.0M$179.0M$15.0M$70.0M
Cash$91.0M$83.0M$38.0M$64.0M$110.0M
Borrowings$209.0M$12.0M$12.0M$9.0M$2.0M

Latest News

Is CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Undervalued Ahead of Key CMP-002 Clinical Development Milestones? Insider Monkey · Jul 2, 2026 X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors GlobeNewswire · Jul 1, 2026 CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 19, 2026 Sector Update: Healthcare Stocks Ease Late Afternoon MT Newswires · Jun 16, 2026 Sector Update: Healthcare MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-39.0M$-44.0M$-46.0M$-30.0M
Investing Cash Flow$-21.0M$-8.0M$-1.0M$-1.0M$-1.0M
Financing Cash Flow$-3.0M$100.0M$0$72.0M$15.0M
Net Cash Flow$-15.0M$83.0M$-45.0M$26.0M$46.0M
Free Cash Flow$-18.0M$-43.0M$-45.0M$-46.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-27.40%
Quick Ratio6.15
Interest Coverage—
Return 1Y204.17%
Return 3Y—
Return 5Y—

Ownership

Insiders Held13.07%
Institutions Held86.72%
Institutions Float Held99.76%
Institutional HolderSharesReport Date
Janus Henderson Group PLC6,307,6362026-03-31
5AM Venture Management, LLC5,869,0912026-03-31
FMR, LLC4,933,4322026-03-31
Vivo Capital, LLC4,246,5682026-03-31
Balyasny Asset Management LP2,632,4372026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ALXO $1.95 -2.26% -1.04 $261.72M 0.00%
ATYR $0.49 +1.19% -0.72 $47.62M 0.00%
BMEA $1.22 +0.00% -1.20 $88.21M 0.00%
HYFT $1.29 -4.44% -1.77 $60.61M 0.00%

About CAMP

CAMP is led by CEO Joshua Mandel-Brehm, employs 55 people, headquartered in US, publicly traded since 2024.

CAMP stock trades at $3.47 with a market capitalization of $73.70M. The stock is valued at a price-to-earnings (P/E) ratio of -1.70, price-to-book of 2.00, price-to-sales of 24.35. Over the past 52 weeks the stock has ranged between $1.32 and $7.75, and currently trades 55.2% below its 52-week high.

On profitability, CAMP generates a return on equity (ROE) of -166.67%, return on capital employed of -108.33%, an operating margin of -1733.33%, a net profit margin of -21.94%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides